Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma

Brain Tumor Pathology

Volumn 32, Issue 3, 2015, Pages 184-194

  Onishi, Manabu ^a   Ichikawa, Tomotsugu ^a   Kurozumi, Kazuhiko ^a   Inoue, Satoshi ^a   Maruo, Tomoko ^a   Otani, Yoshihiro ^a   Fujii, Kentaro ^a   Ishida, Joji ^a   Shimazu, Yosuke ^a   Yoshida, Koichi ^a   Michiue, Hiroyuki ^a   Antonio Chiocca, E ^b   Date, Isao ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Brigham and Women's/Faulkner Hospitals   (United States)

Author keywords

Angiogenesis; Animal model; Annexin A2; Glioma; Invasion

Indexed keywords

LIPOCORTIN 2; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN; PLATELET-DERIVED GROWTH FACTOR A; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; ENDOTHELIUM CELL; GLIOBLASTOMA; GLIOMA CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR INVASION; ANIMAL; BRAIN TUMOR; CELL CULTURE; DISEASE MODEL; FEMALE; FISCHER 344 RAT; GENE EXPRESSION; GENETICS; GLIOMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; ANNEXIN A2; BRAIN NEOPLASMS; CELL ADHESION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; RATS, INBRED F344; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84937974710     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-015-0216-6     Document Type: Article

References (29)

1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996
2. Onishi M, Ichikawa T, Kurozumi K, Date I (2011) Angiogenesis and invasion in glioma. Brain Tumor Pathol 28(1):13–24
3. Inoue S, Ichikawa T, Kurozumi K et al (2012) Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas. World Neurosurg 78(6):670–682
4. Maruo T, Ichikawa T, Kanzaki H et al (2013) Proteomics-based analysis of invasion-related proteins in malignant gliomas. Neuropathology 33(3):264–275
5. Tatenhorst L, Rescher U, Gerke V, Paulus W (2006) Knockdown of annexin 2 decreases migration of human glioma cells in vitro. Neuropathol Appl Neurobiol 32(3):271–277
6. Onishi M, Ichikawa T, Kurozumi K et al (2013) Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models. Neuropathology 33(2):162–174
7. Godiksen S, Selzer-Plon J, Pedersen ED et al (2008) Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary. Biochem J 413(2):251–259
8. Nakamori S, Okamoto H, Kusama T et al (1997) Increased endothelial cell retraction and tumor cell invasion by soluble factors derived from pancreatic cancer cells. Ann Surg Oncol 4(4):361–368
9. Ichikawa T, Tamiya T, Adachi Y et al (2000) In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Ther 7(1):74–82
10. Moss SE, Morgan RO (2004) The annexins. Genome Biol 5(4):219
11. Emoto K, Sawada H, Yamada Y et al (2001) Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 21(2B):1339–1345
12. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI (2008) Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98(2):426–433
13. Esposito I, Penzel R, Chaib-Harrireche M et al (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208(5):673–685
14. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC (2006) Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 81(2):146–156
15. Zimmermann U, Woenckhaus C, Pietschmann S et al (2004) Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch 445(4):368–374
16. Syed SP, Martin AM, Haupt HM, Arenas-Elliot CP, Brooks JJ (2007) Angiostatin receptor annexin II in vascular tumors including angiosarcoma. Hum Pathol 38(3):508–513
17. Reeves SA, Chavez-Kappel C, Davis R, Rosenblum M, Israel MA (1992) Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. Cancer Res 52(24):6871–6876
18. Roseman BJ, Bollen A, Hsu J, Lamborn K, Israel MA (1994) Annexin II marks astrocytic brain tumors of high histologic grade. Oncol Res 6(12):561–567
19. Iwadate Y, Sakaida T, Hiwasa T et al (2004) Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res 64(7):2496–2501
20. Rescher U, Gerke V (2004) Annexins–unique membrane binding proteins with diverse functions. J Cell Sci 117(Pt 13):2631–2639
21. Sharma MC, Sharma M (2007) The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 13(35):3568–3575
22. Tressler RJ, Updyke TV, Yeatman T, Nicolson GL (1993) Extracellular annexin II is associated with divalent cation-dependent tumor cell-endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. J Cell Biochem 53(3):265–276
23. Jung Y, Wang J, Song J et al (2007) Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood 110(1):82–90
24. Bao H, Jiang M, Zhu M, Sheng F, Ruan J, Ruan C (2009) Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol 90(2):177–185
25. Zhao SH, Pan DY, Zhang Y, Wu JH, Liu X, Xu Y (2010) Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization. Chin Med J (Engl) 123(6):713–721
26. Zagzag D, Amirnovin R, Greco MA et al (2000) Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80(6):837–849
27. de Groot JF, Fuller G, Kumar AJ et al (2010) Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol 12(3):233–242
28. Sun H, Guo D, Su Y, Yu D, Wang Q et al (2014) Hyperplasia of pericytes is one of the main characteristics of microvascular architecture in malignant glioma. PLoS One 9(12):e114246
29. Kesavan K, Ratliff J, Johnson EW et al (2010) Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J Biol Chem 285(7):4366–4374